Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: A prospective, multi-institutional, phase II trial

被引：2

作者：

Mizuma, Masamichi

Motoi, Fuyuhiko

Ishida, Kazuyuki

Fujishima, Fumiyoshi

Ottomo, Shigeru

Oikawa, Masaya

Okada, Takaho

Shimamura, Hiromune

Takemura, Shinichi

Ono, Fuminori

Akada, Masanori

Nakagawa, Kei

Katayose, Yu

Egawa, Shinichi

Unno, Michiaki

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan

[2] Iwate Med Univ, Dept Mol Diagnosit Pathol, Morioka, Iwate 020, Japan

[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan

[4] Sendai Open Hosp, Sendai, Miyagi, Japan

[5] Sendai Med Ctr, Sendai, Miyagi, Japan

[6] Shirakawa Kousei Hosp, Shirakawa, Japan

[7] Senboku Kumiai Gen Hosp, Dept Surg, Daisen, Japan

[8] South Miyagi Med Ctr, Dept Surg, Ogawara, Japan

[9] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan

[10] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan

[11] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期

关键词：

D O I：

10.1200/jco.2014.32.3_suppl.283

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

283

引用

页数：1

共 50 条

[41] A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
Yuichi Nagakawa
Yuichi Hosokawa
Hidetsugu Nakayama
Yatsuka Sahara
Chie Takishita
Tetsushi Nakajima
Yousuke Hijikata
Kazuhiko Kasuya
Kenji Katsumata
Koichi Tokuuye
Akihiko Tsuchida
Cancer Chemotherapy and Pharmacology, 2017, 79 : 951 - 957
[42] HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma
Toru Nakamura
Tsuyoshi Hayashi
Yasutoshi Kimura
Hiroshi Kawakami
Kuniyuki Takahashi
Hirotoshi Ishiwatari
Takuma Goto
Masayo Motoya
Keisuke Yamakita
Yusuke Sakuhara
Michihiro Ono
Eiichi Tanaka
Makoto Omi
Katsuhiko Murakawa
Tomoya Iida
Tamaki Sakurai
Shin Haba
Takehiro Abiko
Yoichi M. Ito
Hiroyuki Maguchi
Satoshi Hirano
Scientific Reports, 12 (1)
[43] A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
Nagakawa, Yuichi
Hosokawa, Yuichi
Nakayama, Hidetsugu
Sahara, Yatsuka
Takishita, Chie
Nakajima, Tetsushi
Hijikata, Yousuke
Kasuya, Kazuhiko
Katsumata, Kenji
Tokuuye, Koichi
Tsuchida, Akihiko
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (05) : 951 - 957
[44] A Phase II Trial of Neoadjuvant S-1 Therapy in Patients With Resectable Pancreatic Adenocarcinoma: HOPS-R01
Nakamura, T.
Kawakami, H.
Takahashi, K.
Kimura, Y.
Hayashi, T.
Ishiwatari, H.
Motoya, M.
Goto, T.
Yamakita, K.
Sakuhara, Y.
Maguchi, H.
Hirano, S.
PANCREAS, 2019, 48 (10) : 1496 - 1496
[45] HOPS-R01 phase II trial evaluating neoadjuvant S-1 therapy for resectable pancreatic adenocarcinoma
Nakamura, Toru
Hayashi, Tsuyoshi
Kimura, Yasutoshi
Kawakami, Hiroshi
Takahashi, Kuniyuki
Ishiwatari, Hirotoshi
Goto, Takuma
Motoya, Masayo
Yamakita, Keisuke
Sakuhara, Yusuke
Ono, Michihiro
Tanaka, Eiichi
Omi, Makoto
Murakawa, Katsuhiko
Iida, Tomoya
Sakurai, Tamaki
Haba, Shin
Abiko, Takehiro
Ito, Yoichi M.
Maguchi, Hiroyuki
Hirano, Satoshi
SCIENTIFIC REPORTS, 2022, 12 (01):
[46] Quality of life in a multicenter phase II trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma
Aybar, Pablo Emilio Serrano
Herman, Joseph M.
Zalupski, Mark
Kim, Edward Jae-Hoon
Ben-Josef, Edgar
Bekaii-Saab, Tanios S.
Wolfgang, Christopher Lee
Laheru, Daniel A.
Moore, Malcolm J.
Dawson, Laura A.
Ringash, Jolie
Wei, Alice Chia-chi
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
[47] Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population
Walpole, Imogen
Lee, Belinda
Shapiro, Jeremy
Thomson, Benjamin
Lipton, Lara
Ananda, Sumitra
Usatoff, Val
Mclachlan, Sue-Ann
Knowles, Brett
Fox, Adrian
Wong, Rachel
Cooray, Prasad
Burge, Matthew
Clarke, Kate
Pattison, Sharon
Nikfarjam, Mehrdad
Tebbutt, Niall
Harris, Marion
Nagrial, Adnan
Zielinski, Rob
Chee, Cheng Ean
Gibbs, Peter
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (01) : 214 - 225
[48] Use and Outcomes from Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Ductal Adenocarcinoma in an Australasian Population
Lee, Belinda
Walpole, Imogen
Shapiro, Julia
Thomson, Benjamin
Lipton, Lara
Ananda, Sumitra
Usatoff, Val
Mclachlan, Sue-Anne
Knowles, Brett
Fox, Adrian
Wong, Rachel
Cooray, Prasad
Burge, Matthew
Clarke, Kate
Pattison, Sharon
Nikfarjam, Mehrdad
Tebbutt, Niall
Harris, Marion
Nagrial, Adnan
Zielinski, Rob
Chee, Cheng Ean
Gibbs, Peter
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 175 - 175
[49] ASO Visual Abstract: Results of a Randomized Clinical Study of Gemcitabine Plus Nab-Paclitaxel versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma (RCT, CSGO-HBP-015)
Yamada, Daisaku
Kobayashi, Shogo
Takahashi, Hidenori
Iwagami, Yoshifumi
Akita, Hirofumi
Asukai, Kei
Shimizu, Junzo
Yamada, Terumasa
Tanemura, Masahiro
Yokoyama, Shigekazu
Tsujie, Masanori
Asaoka, Tadafumi
Takeda, Yutaka
Morimoto, Osakuni
Tomokuni, Akira
Doki, Yuichiro
Eguchi, Hidetoshi
ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5215 - 5216
[50] Neoadjuvant gemcitabine and S-1 in pancreatic ductal adenocarcinoma: Effects on nutritional status and pancreaticoduodenectomy outcomes
Takamoto, Takeshi
Nara, Satoshi
Ban, Daisuke
Mizui, Takahiro
Miyata, Akinori
Esaki, Minoru
SURGERY, 2025, 180

← 1 2 3 4 5 →